Skip to main content
Earnings Labs
Prime Medicine, Inc. logo

Prime Medicine, Inc. (PRME)

NASDAQ·Healthcare·Biotechnology

$2.92

+3.74%

Mkt Cap $527.40M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (6 analysts)

$7.00

Range $6.00$8.00

Implied Upside

+139.7%

Consensus $7.00 vs current $2.92